Real Estate
Live Price
Offline$21.55
+1.51% today
1Y Change
+17.42%
Window
Jun 30, 2025 → Jun 23, 2026
Coverage: 246 bars · Jun 30, 2025 → Jun 23, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Healthpeak Properties, Inc. (DOC) is a Real Estate stock with a market cap of $11.48B and listed on NYSE. The stock last traded around $21.55 and up 17.4% across the available one-year price window (Jun 30, 2025 → Jun 23, 2026). Baseline metrics include revenue growth of +4.5%, EPS growth of -72.2%, a dividend yield of 7.4%. What stands out right now is revenue +4.5%, EPS -72.2%, free cash flow +7.1% with operating margin 14.4% and ROIC 18.9%. The dividend matters to the case here, with a current yield around 7.4%. Valuation already assumes a fairly strong business story at P/E 51.7 and price/sales 4.0. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines DOC price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Real Estate peers on this page.
Benchmark Edge
Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.
Relative Read
DOC is 1.31 pts behind over the shared 1Y window.
DOC had 9.40 pts deeper max drawdown than SPY.
DOC beat SPY in 1 of 2 calendar years shown and trailed in 1.
DOC
+17.42%
Normalized return
SPY
+18.73%
S&P 500
Excess Return
-1.31 pts
Relative to SPY
DOC Max Drawdown
-18.53%
Trailing 1Y
SPY Max Drawdown
-9.13%
Trailing 1Y
Uses the longest available daily history for DOC and SPY.
| Year | DOC | SPY | Excess | Leader |
|---|---|---|---|---|
| 2026 | +26.91% | +6.71% | +20.21 pts | DOC |
| 2025 | -7.60% | +11.19% | -18.79 pts | SPY |
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$1.9B
-8.0% YoY
FY Net Income
$505.5M
+1.0% YoY
Free Cash Flow
$795.2M
-11.7% YoY
Revenue Growth
+4.5%
EPS Growth
-72.2%
Gross Margin
21.2%
Net Margin
7.7%
Income statement
USD
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 2.8B | 2.7B | 2.2B | 2.1B | 1.9B |
| Gross Profit | 635M | 1.6B | 1.3B | 1.2B | 1.1B |
| Operating Income | 544M | 471M | 434M | 357M | 340M |
| EBITDA | 1.6B | 1.6B | 1.3B | 1.4B | 971M |
| Net Income | 71M | 243M | 306M | 500M | 506M |
| EPS (Diluted) | — | — | — | — | — |
Balance sheet
USD
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Cash & Equivalents | 538M | 120M | 118M | 72M | 158M |
| Total Assets | 20.3B | 19.9B | 15.7B | 15.8B | 15.3B |
| Total Liabilities | 12.0B | 10.9B | 8.8B | 8.5B | 8.1B |
| Shareholder Equity | 7.5B | 8.4B | 6.4B | 6.7B | 6.5B |
| Total Debt | 10.4B | 9.0B | 7.1B | 6.7B | 6.4B |
| Net Debt | 9.9B | 8.9B | 7.0B | 6.6B | 6.2B |
Cash flow positioning
Latest Full Year
Operating Cash Flow
795M
-11.7% YoY
Capital Expenditures
0
Free Cash Flow
795M
-11.7% YoY
Key ratios
Gross Margin
21.2%
Operating Margin
14.4%
Net Margin
7.7%
ROE
2.9%
Debt / Equity
0.00x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.